COMMITTEE MEMBERSHIP

Org Chart | Executive Committee | Neurocognition Committee | Neuropharmacology Committee
Government/Industry Committee | New Approaches Committee

EXECUTIVE COMMITTEE

  1. Stephen Marder, M.D. (UCLA) – Chair
  2. Michael Green, Ph.D. (UCLA) - Co-Chair
  3. David Braff, M.D. (UCSD)
  4. Daniel Bush, Ph.D. (Best Practice)
  5. Kenneth Davis, M.D. (Mt. Sinai School of Medicine)
  6. Jeffrey Lieberman, Ph.D. (NAMHC)
  7. James P. McNulty (NAMI & NAMHC)
  8. Keith Nuechterlein, Ph.D. (UCLA)
  9. Edward Scolnick, M.D. (Merck Research Laboratories)
  10. Ellen Stover, Ph.D. (NIMH)
  11. Carol Tamminga, M.D. (Maryland Psychiatric Research Center)

NEUROCOGNITION COMMITTEE

  1. Keith Nuechterlein, Ph.D. (UCLA) - Co-Chair
  2. Michael Green, Ph.D. (UCLA) - Co-Chair
  3. Deanna Barch, Ph.D. (Washington University)
  4. Jonathan Cohen, M.D., Ph.D. (Princeton University)
  5. Susan Essock, Ph.D. (MSSM, Mount Sinai School of Medicine)
  6. Fred Frese, Ph.D. (NAMI)
  7. Jim Gold, Ph.D. (Maryland Psychiatric Research Center)
  8. Terry Goldberg, Ph.D. (NIMH)
  9. Robert Heaton, M.D. (UCSD)
  10. Richard Keefe, Ph.D. (Duke University)
  11. Helena Kraemer, Ph.D. (Stanford University)
  12. Ellen Stover, Ph.D. (NIMH)
  13. Daniel Weinberger, M.D. (NIMH)
  14. Steve Zalcman, M.D. (NIMH)

NEUROPHARMACOLOGY COMMITTEE

  1. Carol Tamminga, M.D. (Maryland Psychiatric Research Center) - Co-Chair
  2. Mark Geyer, Ph.D. (UCSD) - Co-Chair
  3. Floyd Bloom, M.D. (Scripps)
  4. Linda Brady, Ph.D. (NIMH)
  5. Robert Buchanan, M.D. (Maryland Psychiatric Research Center)
  6. Robert Freedman, M.D. (University of Colorado)
  7. Donald Goff, M.D. (Harvard University)
  8. Stephen Marder, M.D. (UCLA)
  9. Eric Nestler, M.D., Ph.D. (University of Texas Southwestern Medical Center & NAMHC)
  10. Ellen Stover, Ph.D. (NIMH)

GOVERNMENT/INDUSTRY COMMITTEE

  1. Daniel Bush, Ph.D. (Best Practice) - Chair
  2. Linda Brady, Ph.D. (NIMH)
  3. Mark Brann, Ph.D. (Acadia Pharmaceuticals)
  4. Michael Knable, D.O.(Stanley Research Foundation)
  5. Roger Meyer, M.D. (Best Practice)
  6. Willam Potter, M.D. (Lilly Pharmaceuticals )
  7. Steve Zalcman, M.D. (NIMH)
  8. Edward Scolnick, M.D. (Merck Research Laboratories)
  9. Ilisa Smukler, Esq.(South Florida State Hospital)
  10. Werner Rein, M.D. (Sanofi-Synthelabo)

NEW APPROACHES COMMITTEE

  1. Mark Geyer, Ph.D. (UCSD) – Co-Chair
  2. Robert Heinssen, Ph.D. (NIMH) – Co-Chair
  3. Deanna Barch, Ph.D. (Washington University)
  4. Linda Brady, Ph.D. (NIMH)
  5. Cameron Carter, M.D. (UC Davis)
  6. Robert Freedman, M.D. (University of Colorado)
  7. Anthony Grace, Ph.D. (University of Pittsburgh)
  8. Michael Green, Ph.D. (UCLA)
  9. Stephen Marder, M.D. (UCLA)
  10. Keith Nuechterlein, Ph.D. (UCLA)
  11. Ellen Stover, Ph.D. (NIMH)
  12. Dan Weinberger, M.D. (NIMH)
  13. Steve Zalcman, M.D. (NIMH)
MATRICS Footer

Contact matricsassessment@gmail.com for questions or comments about the MATRICS program and see our website - www.matricsinc.org - for details regarding the MATRICS Consensus Cognitive Battery (MCCB).

Contact support@matrics.ucla.edu for questions or comments about with this web site.

TURNS Home Page | UCLA Home Page | Terms of Use | Disability Resources at UCLA